닥플 플러스
HCC 2026: Bridging Biology, Technology, and Multidisciplinary Care
융합간암연구회
연수평점 :3점
오프라인
주관
융합간암연구회
교육일자
2026-10-17
수강료
20,000원
교육형태
오프라인
등록일시
2026-08-25
교육시간
3시간 50분
연수평점
3점
장소
전남광주통합특별시 김대중 컨벤션센터3층 305-306호
교육종류
내과, 외과, 영상의학과, 방사선종양학과, 의사학, 의학교육
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-10-17 | 10:10~10:35 | Epidemiology and current trends of liver cancer | 원영주(연세대학교) | - |
| 2026-10-17 | 10:35~11:00 | Risk factors and prevention strategies: from viral hepatitis to metabolic liver disease | 조현진(경상의대) | - |
| 2026-10-17 | 11:00~11:15 | - | - | - |
| 2026-10-17 | 11:15~11:40 | Liquid Biopsy and Biochip Platforms for Early Cancer Detection and Treatment Monitoring: From Bench to Clinic | 임은경(한국생명공학연구원 바이오나노연구센터) | - |
| 2026-10-17 | 11:40~12:05 | AI prediction model using peripheral immunologic T cell biomarkers and clinical impacts | 조재호(전남의대) | - |
| 2026-10-17 | 12:05~12:35 | Circulating tumor DNA (ctDNA) as MRD biomarker after HCC resection: clinical utility and future directions | 왕희정(인제의대) | - |
| 2026-10-17 | 12:35~13:35 | - | - | - |
| 2026-10-17 | 13:35~14:00 | Current status and future perspectives of neoadjuvant and adjuvant therapy for resectable HCC | 송정은(대구가톨릭의대) | - |
| 2026-10-17 | 14:00~14:25 | MRI-based Imaging Biomarkers for Prognosis prediction in HCC | 주이진(서울의대) | - |
| 2026-10-17 | 14:25~14:40 | - | - | - |
| 2026-10-17 | 14:40~15:05 | TACE + immunotherapy combinations (EMERALD-1/3, LEAP-012): changing the paradigm in intermediate HCC | 허정(부산의대) | - |
| 2026-10-17 | 15:05~15:30 | Radiotherapy for HCC in the Immunotherapy Era: Where Do We Stand? | 박신형(경북의대 ) | - |
문의처
담당자
이동주
연락처
053-200-5966
이메일
erinkloi@naver.com